CCT Coating & Converting Technologies Inc has developed a particular strength in the healthcare sector.
CCT’s founder Robert Dempsey as well as CEO Rich Hipp together with their team will continue to run the firm’s operations from their Philadelphia location.
ATP says that its R&D and coating expertise as well as CCT’s long-established presence and reputation in the US market are complementary. The management teams of both companies expect to significantly increase its service offering especially to its US customers.
“We will significantly invest into CCT’s operations to provide its North American customers with the best possible product. Our acquisition of CCT again highlights ATP’s strong ambition to expand internationally and further diversify its offering,” said Daniel Heini, CEO ATP.
Investor Bregal Unternehmerkapital has acquired ATP in 2019 and together with its management team is focussing on expanding the business globally.